VivoSeq
Other

Analgesic Efficacy

0

Pipeline Programs

14

Active Trials

9

Companies Involved

Analgesic Efficacy is an early-stage landscape with 0 programs across 9 companies. The most active players are Bayer, AstraZeneca, Xanodyne Pharmaceuticals.

Pipeline Metrics

Competitive Density

31/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

94/100

Attrition Rate

4/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

75

clinical trials

Completed49 · 65%
Recruiting10 · 13%
Unknown status9 · 12%
Not yet recruiting4 · 5%
Terminated3 · 4%

Trial Activity

75 trials

Analgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin
Not yet recruiting··Phase 2/3·NCT07047040·86 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)